Informatie:
Fout:
ID
34431
Beschrijving
Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT02486354
Link
https://clinicaltrials.gov/show/NCT02486354
Trefwoorden
Versies (1)
- 17-01-19 17-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
17 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Non-small Cell Lung Cancer NCT02486354
Eligibility Non-small Cell Lung Cancer NCT02486354
- StudyEvent: Eligibility
Similar models
Eligibility Non-small Cell Lung Cancer NCT02486354
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
histologically or cytologically confirmed locally advanced/metastatic (stage iiib/stage iv, using the american joint committee on cancer [ajcc] 6th edition of tumor-node-metastasis [tnm] staging system) nsclc patients
boolean
ID.2
Item
progressed after at least one platinum-based chemotherapy regimen at entry
boolean
ID.3
Item
eastern cooperative oncology group (ecog) performance status (ps) 0-2
boolean
ID.4
Item
at least one measurable lesion by response evaluation criteria in solid tumors version 1.0
boolean
ID.5
Item
adequate hematologic and biochemical values
boolean
ID.6
Item
patients with symptomatic brain metastases
boolean
ID.7
Item
malignant tumor within the previous five years
boolean
ID.8
Item
severe infection; congestive heart failure
boolean
ID.9
Item
previous treatment with drugs targeting egfr
boolean
ID.10
Item
history of interstitial lung disease
boolean